business

Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older - Yahoo Finance

PHILADELPHIA, March 25, 2025--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for...

By:Business Wire
Source:Yahoo Entertainment
Published:
Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older - Yahoo Finance
  • Blujepa is the first in a new class of oral antibiotics for uUTIs in nearly 30 years
  • Over half of all women experience a uUTI in their lifetime, with approximately 30% suffering fro… [+13538 chars]

Related News